Please login to the form below
clinical data
This page shows the latest clinical data news and features for those working in and with pharma, biotech and healthcare.
FDA expecting boom in cell and gene therapies
The nature of gene therapy means that questions about the durability of therapeutic benefit and off-target effects may not be answerable in clinical trials before licensing, so it ill be ... That aside, the intention isn’t to block research, and the
Latest news
-
Axovant drops last ‘legacy’ drug to focus on gene therapies
Axovant has been focused on developing innovative gene therapies and we will not undertake further clinical studies with our legacy small molecule portfolio,” said Pavan Cheruvu, the company’s chief executive. ... After recent meeting with the FDA,
-
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
Invests in Genomics England alliance, plus clinical trials expansion. Human data sciences and clinical trials company IQVIA has unveiled a major new investment in the UK, tapping into the country’s ... This involves opening a fourth in its UK ‘Prime
-
Shire’s angioedema drug Takhzyro claims EU approval
The EU regulator has cleared Takhzyro (lanadelumab) for the preventive treatment of HAE in patients aged over 12, based on clinical data showing that the drug can reduce HAE attacks – typically
-
Avenir acquires Cherry, EY wins new account and GK unites businesses
Sensyne is currently in the process of creating a framework for the ethical commercial use of patient medical data. ... It hopes healthcare providers along with life sciences companies will use its clinical AI technology to analyse anonymised data, which
-
AZ drug matched to cancer mutation passes phase 2 test
More data from promising class of targeted small molecule drugs. A drug developed by AstraZeneca that targets a specific cancer mutation called AKT E17K has shown activity in a phase 2 ... Meanwhile, this isn’t the first clinical data for capivasertib,
More from news
Approximately 0 fully matching, plus 728 partially matching documents found.
Latest Intelligence
-
Is China ready for a pharmaceutical gold rush?
What’s more, requirements to carry out local clinical trials before being granted access to the Chinese market have relaxed. ... In light of recent clinical data, Keytruda is widely regarded as the better of the two checkpoint inhibitors in lung cancer.
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Onpattro looked to have the edge in terms of clinical data, but Pfizer has new data showing tafamidis is effective in treating patients with cardiomyopathy – the heart damage caused by the ... and sustainable clinical pipeline and a robust product
-
Lonely planet: why there is dwindling value in pharma travelling alone
But, says Vernon, we haven’t reached nirvana yet. “There are still issues around data availability and integration. ... cycle to outcomes- based payments and incentivising individual people to safely use their own health data for the betterment of
-
Stakeholder dialogue in Europe’s adaptive pathways pilot
The AP approach is designed for products in therapeutic areas of high unmet need and for which it may be difficult to generate clinical data via the regular route. ... Efficacy and safety data from early compassionate use programmes to supplement
-
The critical role of science in healthcare communications
As a result, they can help develop more creative and effective communications solutions based on clinical data that supports safe and effective use of a new drug and under what conditions. ... clinical goals and industry goals.
More from intelligence
Approximately 0 fully matching, plus 91 partially matching documents found.
Latest appointments
-
Orchard Therapeutics appoints Mark Rothera as CEO
He joins from PTC Therapeutics. London, UK-based Orchard Therapeutics has appointed Mark Rothera as its new president and chief executive officer at a time when the group progresses its clinical ... The clinical data we’ve seen to date with Orchard’s
-
Clinerion appoints new regional head
Bariş Erdoğan takes up new role at the clinical trial data firm. ... Swiss-based clinical trial data firm Clinerion has appointed Bariş Erdoğan as its new regional head in a role that focuses on the expansion of its activities in Eastern Europe, the
-
Novocure’s chief commercial officer to step down
clinical data in Q4 2014.
-
J&J’s clinical research neuroscience director joins MedAvante
Dr Michael Ropacki becomes head of R&D at the clinical data service. ... Global clinical data services company MedAvante has appointed Dr Michael Ropacki as vice president of research and development.
-
Quanticate names chief operating officer
Alan Morgan joins the data-focused clinical research organisation. London-based clinical research organisation Quanticate has appointed Alan Morgan as its chief operating officer. ... As the clinical data experts, Alan's leadership over our operational
More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.
Latest from PMHub
-
NHS Long Term Plan - Digital is firmly on the agenda. Are you ready?
Clinical, genomic and other data will be linked to support the development of new treatments to improve the NHS, making data captured for care available for clinical research, and publish, as ... By harnessing industry data and utilising the latest
-
Highlights in haematologic malignancy from ASH 2018
None is yet approved; however, the data appear to be very promising. ... The new algorithm uses patients’ genomic and clinical data to determine prognosis, outperforming the current gold standard tool for predicting survival and development of AML.
-
Artificial Intelligence in Healthcare
Or providing never-seen-before clinical decision support, with AI scouring a vast breadth of data to return evidence-based clinical protocols. ... But, with a joined-up digital healthcare system, robust clinical data sets, and the help of AI, why can’t
-
Digital Marketing is no Substitute for Sound Strategic Marketing
In the mid 1990’s pharmaceutical companies embraced strategic marketing to differentiate their products beyond clinical data and maintain competitive advantage. ... clinical data and always prescribed rationally.
-
Three key development areas in the management of multiple sclerosis
Clinical trial and real-world data supporting the efficacy of disease-modifying therapies in newly diagnosed and early MS were presented at the ECTRIMS congress. ... The data showed that the majority of patients remained free from confirmed disability
More from PMHub
Approximately 1 fully matching, plus 57 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director
-
Competitive Salary Offered
- Global Business Development Director – Health Education
-
excellent commission
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
Subscribe to our email news alerts
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
PMHub
Star
We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
